Clinical Evaluation of Investigational Multifocal Toric Contact Lenses

NCT03519282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2020-05-04

Study results available
· View outcomes & findings →

Summary

This non-dispensing study is to evaluate the clinical performance of a test multifocal toric silicone hydrogel contact lens compared to a marketed multifocal toric contact lens (control).

Conditions

Interventions

DEVICE

comfilcon A multifocal toric lens

contact lens

DEVICE

omafilcon A Multifocal Toric Lens

contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip Morgan, BSc, PhD, MCOptom · Eurolens Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2018-07-24
Completion
2018-07-24
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03519282 on ClinicalTrials.gov